Cardiovascular diseases
Pro Research Analysisby 
Searched over 200M research papers for "cardiovascular diseases"
Cardiovascular Diseases: Global Impact and Public Health Burden
Cardiovascular diseases (CVDs) are the leading cause of death and disability worldwide, accounting for a significant proportion of global morbidity and mortality. They include a range of disorders affecting the heart and blood vessels, such as coronary artery disease, cerebrovascular disease, venous thromboembolism, and peripheral vascular disease. The chronic nature of CVDs means they can remain undetected for long periods, further increasing their public health impact and socio-economic burden Frąk2022Flora2019Gaidai2023.
Major Causes and Pathophysiology: Atherosclerosis, Hypertension, and Inflammation
Atherosclerosis is the primary underlying cause of most CVDs. It involves the buildup of fatty deposits in the arteries, leading to reduced blood flow and increased risk of heart attacks and strokes. Key mechanisms in the development of CVDs include endothelial dysfunction, chronic inflammation, and oxidative stress. These processes are influenced by molecular and cellular factors such as matrix metalloproteinases, immune system components, and genetic predispositions. Arterial hypertension, or high blood pressure, is another major contributor, often interacting with atherosclerosis to worsen disease progression Frąk2022Flora2019.
Recognized Risk Factors: Lifestyle, Genetics, and Environment
The most significant risk factors for CVDs are well established and include high cholesterol, hypertension, diabetes, obesity, smoking, and physical inactivity. These factors account for over 90% of CVD risk in epidemiological studies. Family history, age, gender, and stress also play important roles. While some CVDs, like familial hypercholesterolemia and certain cardiomyopathies, are linked to specific genetic mutations, most common forms of CVD are influenced by many genetic variants, each with a small effect. This complexity is now being captured through polygenic risk scores, which help in individual risk prediction Frąk2022Flora2019Rahim2021+2 MORE.
Advances in Diagnosis and Prediction: Machine Learning and Genetic Testing
Recent years have seen significant progress in the early detection and prediction of CVDs using artificial intelligence (AI) and machine learning (ML) techniques. These approaches analyze large clinical datasets to identify patterns and risk factors, improving the accuracy of CVD prediction. Ensemble models and frameworks combining multiple algorithms have achieved high accuracy in predicting CVD risk, making them valuable tools for clinicians. Additionally, genetic testing, including polygenic risk scoring, is becoming more accessible and offers new opportunities for personalized risk assessment and preventive strategies Rahim2021Pandey2025Tiwari2022+2 MORE.
Current Treatment and Prevention Strategies
The primary strategies for preventing and treating CVDs focus on managing risk factors through lifestyle changes and medications. Common treatments include lipid-lowering drugs, antihypertensives, antiplatelet agents, and anticoagulants. While these therapies are effective, there are still gaps in treatment coverage and outcomes, highlighting the need for continued research and improved healthcare delivery .
Conclusion
Cardiovascular diseases remain a major global health challenge due to their high prevalence, complex causes, and significant impact on mortality and healthcare systems. Advances in understanding the molecular mechanisms, risk factors, and the use of AI and genetic testing are improving early detection and personalized care. However, ongoing research and public health efforts are essential to further reduce the burden of CVDs and improve outcomes for affected individuals Frąk2022Flora2019Rahim2021+6 MORE.
Sources and full results
Most relevant research papers on this topic